Zennoa Holdings, LLC – Trademark Portfolio

Entity Type: 16

Zennoa Holdings, LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 4 Nice Classification classes. The owner is based in Orem, UT.

1426 E 750 N

Orem, UT 84097

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

KIRUS
KIRUS
Abandoned 2018
ZENNOA
ZENNOA
Cancelled 2016
ZENNOA
ZENNOA
Abandoned 2016

Trademark Classifications

Zennoa Holdings, LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (2 filings)

Advertising; business management; business administration; office functions

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

3
Cosmetics & Cleaning (1 filing)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does Zennoa Holdings, LLC have?

Zennoa Holdings, LLC has 4 U.S. trademarks filed with the USPTO.

What trademark classes does Zennoa Holdings, LLC file in?

Zennoa Holdings, LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 44 (Medical Services). Class 35 covers advertising; business management; business administration; office functions.

What is Zennoa Holdings, LLC's trademark registration success rate?

Zennoa Holdings, LLC has a 0% trademark registration rate, with 0 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.